PMID- 18426987 OWN - NLM STAT- MEDLINE DCOM- 20080804 LR - 20220129 IS - 1540-9538 (Electronic) IS - 0022-1007 (Print) IS - 0022-1007 (Linking) VI - 205 IP - 5 DP - 2008 May 12 TI - Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. PG - 1009-17 LID - 10.1084/jem.20072457 [doi] AB - In a study of 114 epidemiologically linked Zambian transmission pairs, we evaluated the impact of human leukocyte antigen class I (HLA-I)-associated amino acid polymorphisms, presumed to reflect cytotoxic T lymphocyte (CTL) escape in Gag and Nef of the virus transmitted from the chronically infected donor, on the plasma viral load (VL) in matched recipients 6 mo after infection. CTL escape mutations in Gag and Nef were seen in the donors, which were subsequently transmitted to recipients, largely unchanged soon after infection. We observed a significant correlation between the number of Gag escape mutations targeted by specific HLA-B allele-restricted CTLs and reduced VLs in the recipients. This negative correlation was most evident in newly infected individuals, whose HLA alleles were unable to effectively target Gag and select for CTL escape mutations in this gene. Nef mutations in the donor had no impact on VL in the recipient. Thus, broad Gag-specific CTL responses capable of driving virus escape in the donor may be of clinical benefit to both the donor and recipient. In addition to their direct implications for HIV-1 vaccine design, these data suggest that CTL-induced viral polymorphisms and their associated in vivo viral fitness costs could have a significant impact on HIV-1 pathogenesis. FAU - Goepfert, Paul A AU - Goepfert PA AD - Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. paulg@uab.edu FAU - Lumm, Wendy AU - Lumm W FAU - Farmer, Paul AU - Farmer P FAU - Matthews, Philippa AU - Matthews P FAU - Prendergast, Andrew AU - Prendergast A FAU - Carlson, Jonathan M AU - Carlson JM FAU - Derdeyn, Cynthia A AU - Derdeyn CA FAU - Tang, Jianming AU - Tang J FAU - Kaslow, Richard A AU - Kaslow RA FAU - Bansal, Anju AU - Bansal A FAU - Yusim, Karina AU - Yusim K FAU - Heckerman, David AU - Heckerman D FAU - Mulenga, Joseph AU - Mulenga J FAU - Allen, Susan AU - Allen S FAU - Goulder, Philip J R AU - Goulder PJ FAU - Hunter, Eric AU - Hunter E LA - eng GR - P30 AI050409/AI/NIAID NIH HHS/United States GR - G0501777/MRC_/Medical Research Council/United Kingdom GR - G0500384/MRC_/Medical Research Council/United Kingdom GR - AI-46995/AI/NIAID NIH HHS/United States GR - R01 AI041951/AI/NIAID NIH HHS/United States GR - R01 AI064060/AI/NIAID NIH HHS/United States GR - WT_/Wellcome Trust/United Kingdom GR - R01 AI046995/AI/NIAID NIH HHS/United States GR - AI-64060/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20080421 PL - United States TA - J Exp Med JT - The Journal of experimental medicine JID - 2985109R RN - 0 (Gene Products, gag) RN - 0 (HLA-B Antigens) RN - 0 (Histocompatibility Antigens Class I) SB - IM MH - Amino Acid Sequence MH - Base Sequence MH - Gene Products, gag/chemistry/*genetics/immunology MH - HIV-1/*genetics/immunology MH - HLA-B Antigens/genetics/immunology MH - Histocompatibility Antigens Class I/immunology MH - Humans MH - *Mutation MH - Polymorphism, Genetic MH - South Africa/epidemiology MH - *Viral Load MH - Zambia/epidemiology PMC - PMC2373834 EDAT- 2008/04/23 09:00 MHDA- 2008/08/05 09:00 PMCR- 2008/11/12 CRDT- 2008/04/23 09:00 PHST- 2008/04/23 09:00 [pubmed] PHST- 2008/08/05 09:00 [medline] PHST- 2008/04/23 09:00 [entrez] PHST- 2008/11/12 00:00 [pmc-release] AID - jem.20072457 [pii] AID - 20072457 [pii] AID - 10.1084/jem.20072457 [doi] PST - ppublish SO - J Exp Med. 2008 May 12;205(5):1009-17. doi: 10.1084/jem.20072457. Epub 2008 Apr 21.